Effectiveness of a whole cell pertussis vaccine in child-care centers and schools
G DE SERRES, N Boulianne, B Duval… - The Pediatric …, 1996 - journals.lww.com
Background Pertussis has substantially increased in Quebec, Canada, since 1990. We
estimated pertussis vaccine effectiveness and vaccine coverage in child-care centers and …
estimated pertussis vaccine effectiveness and vaccine coverage in child-care centers and …
Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy
DP Greenberg, LK Pickering, SD Senders… - …, 2002 - publications.aap.org
Objective. Currently, 4 diphtheria-tetanus-acellular pertussis (DTaP) vaccines are licensed
for pediatric use in the United States, and 2 are commercially available. Although a single …
for pediatric use in the United States, and 2 are commercially available. Although a single …
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience
S Salmaso, P Mastrantonio, AE Tozzi, P Stefanelli… - …, 2001 - publications.aap.org
Background. In 1992–1993, a randomized, double-blind, placebo-controlled clinical trial of
two 3-component acellular pertussis vaccines was started in 4 of Italy's 20 regions. During …
two 3-component acellular pertussis vaccines was started in 4 of Italy's 20 regions. During …
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis
B Trollfors, J Taranger, T Lagergård, L Lind… - The Journal of …, 1997 - Elsevier
In a double-blind, placebo-controlled efficacy trial of a monocomponent pertussis toxoid
vaccine, 3450 infants were randomly assigned to vaccination with diphtheria-tetanus toxoids …
vaccine, 3450 infants were randomly assigned to vaccination with diphtheria-tetanus toxoids …
US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine
TH Skoff, L Deng, CH Bozio, S Hariri - Jama Pediatrics, 2023 - jamanetwork.com
Importance Infants younger than 1 year have the highest burden of pertussis morbidity and
mortality. In 2011, the US introduced tetanus toxoid, reduced diphtheria toxoid, and acellular …
mortality. In 2011, the US introduced tetanus toxoid, reduced diphtheria toxoid, and acellular …
Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers
Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …
Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell …
U Heininger, K Stehr, P Christenson… - Clinical infectious …, 1999 - academic.oup.com
A subanalysis of a recent cohort efficacy trial of a pertussis vaccine was performed to
determine its efficacy against cough illnesses due to Bordetella parapertussis infections …
determine its efficacy against cough illnesses due to Bordetella parapertussis infections …
Acellular pertussis vaccination of 2-month-old infants in the United States
ME Pichichero, AB Francis, MM Blatter… - …, 1992 - publications.aap.org
This is the first study in children from the United States that evaluates the immunogenicity of
and adverse reactions to the Connaught/Biken two-component acellular pertussis vaccine …
and adverse reactions to the Connaught/Biken two-component acellular pertussis vaccine …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
[HTML][HTML] Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019
E Seppälä, AB Kristoffersen, H Bøås, DF Vestrheim… - Vaccine, 2022 - Elsevier
Background The acellular pertussis vaccine has been used in the Norwegian national
immunisation program since 1998. Following an increase in pertussis incidence in all age …
immunisation program since 1998. Following an increase in pertussis incidence in all age …